33 related articles for article (PubMed ID: 38773060)
1. A retrospective analysis of the clinicopathological features and prognostic value of MAPK12 protein expression in diffuse large B-cell lymphoma.
Liu Y; Zhang H; Zhao S; Zhang Y
Clin Transl Oncol; 2024 May; ():. PubMed ID: 38773060
[TBL] [Abstract][Full Text] [Related]
2. Pan-cancer analysis of the prognostic and immunological role of GJB2: a potential target for survival and immunotherapy.
Jia Y; Guo B; Zhang W; Wang F; Zhang Y; Zhang Q; Li E
Front Oncol; 2023; 13():1110207. PubMed ID: 37427102
[TBL] [Abstract][Full Text] [Related]
3. Interaction of RARRES1 with ICAM1 modulates macrophages to suppress the progression of kidney renal clear cell carcinoma.
Geng X; Chi K; Liu C; Fu Z; Wang X; Meng L; Wang H; Cai G; Chen X; Hong Q
Front Immunol; 2022; 13():982045. PubMed ID: 36353618
[TBL] [Abstract][Full Text] [Related]
4. Loss of RARRES1 function Promotes Follicular Lymphomagenesis and Inhibits B cell Differentiation in Mice.
Patel J; Xun D; Creswell K; Kim DK; Wu M; Hwang JW; Kim TS; Bansal S; Hong SH; Galli S; Kim HJ; Deng C; Byers SW; Lee MH
Int J Biol Sci; 2022; 18(7):2670-2682. PubMed ID: 35541897
[TBL] [Abstract][Full Text] [Related]
5. Metastasis and MAPK Pathways.
Kciuk M; Gielecińska A; Budzinska A; Mojzych M; Kontek R
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409206
[TBL] [Abstract][Full Text] [Related]
6. The pro-tumorigenic activity of p38γ overexpression in nasopharyngeal carcinoma.
Yin DP; Zheng YF; Sun P; Yao MY; Xie LX; Dou XW; Tian Y; Liu JS
Cell Death Dis; 2022 Mar; 13(3):210. PubMed ID: 35246508
[TBL] [Abstract][Full Text] [Related]
7. Functional Roles of JNK and p38 MAPK Signaling in Nasopharyngeal Carcinoma.
Pua LJW; Mai CW; Chung FF; Khoo AS; Leong CO; Lim WM; Hii LW
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163030
[TBL] [Abstract][Full Text] [Related]
8. Involvement of miR-769-5p/Retinoic Acid Receptor Responder 1 Axis in the Progression of Osteosarcoma: Characterization of Potential Therapeutic Targets.
Ma L; Ma Y; Lian A
Pharmacology; 2022; 107(3-4):179-187. PubMed ID: 35152215
[TBL] [Abstract][Full Text] [Related]
9. The p38 MAPK Components and Modulators as Biomarkers and Molecular Targets in Cancer.
García-Hernández L; García-Ortega MB; Ruiz-Alcalá G; Carrillo E; Marchal JA; García MÁ
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008796
[TBL] [Abstract][Full Text] [Related]
10. Intratumor heterogeneity: the hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-γ signaling and tumor-infiltrating lymphocytes.
Wu W; Liu Y; Zeng S; Han Y; Shen H
J Hematol Oncol; 2021 Oct; 14(1):160. PubMed ID: 34620200
[TBL] [Abstract][Full Text] [Related]
11. p38β and Cancer: The Beginning of the Road.
Roche O; Fernández-Aroca DM; Arconada-Luque E; García-Flores N; Mellor LF; Ruiz-Hidalgo MJ; Sánchez-Prieto R
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33053909
[TBL] [Abstract][Full Text] [Related]
12. p38γ overexpression promotes osteosarcoma cell progression.
Shi C; Cheng WN; Wang Y; Li DZ; Zhou LN; Zhu YC; Zhou XZ
Aging (Albany NY); 2020 Sep; 12(18):18384-18395. PubMed ID: 32970611
[TBL] [Abstract][Full Text] [Related]
13. A robust 11-genes prognostic model can predict overall survival in bladder cancer patients based on five cohorts.
Lin J; Yang J; Xu X; Wang Y; Yu M; Zhu Y
Cancer Cell Int; 2020; 20():402. PubMed ID: 32843852
[TBL] [Abstract][Full Text] [Related]
14. Using mRNAsi to identify prognostic-related genes in endometrial carcinoma based on WGCNA.
Liu J; Wu Z; Sun R; Nie S; Meng H; Zhong Y; Nie X; Cheng W
Life Sci; 2020 Oct; 258():118231. PubMed ID: 32791150
[TBL] [Abstract][Full Text] [Related]
15. Toward a New Molecular Taxonomy of Diffuse Large B-cell Lymphoma.
Ennishi D; Hsi ED; Steidl C; Scott DW
Cancer Discov; 2020 Sep; 10(9):1267-1281. PubMed ID: 32616477
[TBL] [Abstract][Full Text] [Related]
16. Targeting p38γ to inhibit human colorectal cancer cell progression.
Su C; Sun Q; Liu S; Wang H; Feng L; Cao Y
Biochem Biophys Res Commun; 2019 Sep; 517(1):172-179. PubMed ID: 31349971
[TBL] [Abstract][Full Text] [Related]
17. p38γ is essential for cell cycle progression and liver tumorigenesis.
Tomás-Loba A; Manieri E; González-Terán B; Mora A; Leiva-Vega L; Santamans AM; Romero-Becerra R; Rodríguez E; Pintor-Chocano A; Feixas F; López JA; Caballero B; Trakala M; Blanco Ó; Torres JL; Hernández-Cosido L; Montalvo-Romeral V; Matesanz N; Roche-Molina M; Bernal JA; Mischo H; León M; Caballero A; Miranda-Saavedra D; Ruiz-Cabello J; Nevzorova YA; Cubero FJ; Bravo J; Vázquez J; Malumbres M; Marcos M; Osuna S; Sabio G
Nature; 2019 Apr; 568(7753):557-560. PubMed ID: 30971822
[TBL] [Abstract][Full Text] [Related]
18. Multi-Kinase Inhibitor with Anti-p38γ Activity in Cutaneous T-Cell Lymphoma.
Zhang XH; Nam S; Wu J; Chen CH; Liu X; Li H; McKeithan T; Gong Q; Chan WC; Yin HH; Yuan YC; Pillai R; Querfeld C; Horne D; Chen Y; Rosen ST
J Invest Dermatol; 2018 Nov; 138(11):2377-2387. PubMed ID: 29758280
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
